Navigation Links
ACE Titanium Large Fragment System

ProductsACE Titanium Large Fragment System
Company DePuy Orthopaedics, Inc.
Item ACE Titanium Large Fragment System
Features 
  • Greater strength
  • Increased biocompatibility
  • Enhanced imaging compatibility
  • Innovative implant designs
  • User friendly instrumentation
  • Description The advanced performance benefits of TiMAX™ material have been applied to a new generation of implants. DePuy ACEs Large Fragment plates and screws offer greater strength, increased biocompatibility and enhanced imaging compatibility over traditional titanium and stainless steel implants.

    A unique thread design in the TiMAX bone screws provides greater resistance to pullout, while the double lead thread allows for quicker insertion. The self-tapping tip reduces the need for pre-tapping, saving valuable time in the OR.

    The Large Fragment System contains broad and narrow Active Compression Plates (A.C.P.) which allow for compression, neutralization and buttress modes. Increased screw angulation and axial compression have also been built into the design.

    The "T" and "L" Plates have slotted proximal screw holes for greater angulation, are pre-contoured for specific anatomical applications and are offered in longer lengths to accommodate shaft fractures.
    Info DePuy Orthopaedics, Inc.
    Customer Service: (800) 366-8143
    Web site: http://www.jnjgateway.com/home.jhtml?loc=USENG&page=viewContent&contentId=09008b9880772d01

    Related medicine products :

    1. Hydroview Insertion Forceps - Titanium
    2. Titanium Bayonet Forceps
    3. Titanium Foot Activated Forceps
    4. Craniofix Titanium Clamp
    5. Craniofix Titanium Burr Hole Clamp
    6. Lorenz 1.0 mm Titanium System
    7. Lorenz 2.0 mm Flexible Titanium
    8. Lorenz 1.5 mm Titanium System
    9. Lorenz 2.0 mm Low Profile Titanium
    10. Lorenz 2.0 mm Mini-plate Titanium
    11. Anteater Titanium Microdiscectomy System
    ELISA for detection of Anti-Gliadin IgA....
    An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
    Enzyme immunoassay for the quantitative determination of Gliadin-IgA antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
    ... immunosorbent assay method for the semi-quantitative determination ... human serum. The results of the anti-Gliadin ... aid in the diagnosis of diseases associated ... Coeliac Disease. Levels of these autoantibodies are ...
    Medicine Products:
    (Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
    (Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
    (Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
    (Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
    (Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
    Breaking Medicine News(10 mins):
    (Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
    (Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
    (Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
    Breaking Medicine Technology: